[Influence of glucose blood level on the human plasma inhibitor-alpha 2 (author's transl)].
D007516:Adenoma, Islet Cell / Q000097:blood; D000510:Alpha-Globulins / Q000494:pharmacology*; D000818:Animals; D001609:Beta-Globulins / Q000494:pharmacology*; D001786:Blood Glucose; D003920:Diabetes Mellitus / Q000097:blood*; D003964:Diaphragm / Q000378:metabolism; D005947:Glucose / Q000378:metabolism*; D005951:Glucose Tolerance Test; D013006:Growth Hormone / Q000378:metabolism; D006801:Humans; D007003:Hypoglycemia / Q000097:blood; D009132:Muscles / Q000378:metabolism*; D010902:Pituitary Gland / Q000378:metabolism; D051381:Rats
D000510:Alpha-Globulins; D001609:Beta-Globulins; D001786:Blood Glucose; D013006:Growth Hormone; D005947:Glucose
Influencia de la glucemia sobre el inhibidor-alpha 2 del plasma humano